We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$73.9B
AUM Growth
-$2.32B
Cap. Flow
-$2.03B
Cap. Flow %
-2.75%
Top 10 Hldgs %
22.54%
Holding
3,088
New
93
Increased
1,359
Reduced
1,564
Closed
46

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$60.7M
2
ADI icon
Analog Devices
ADI
+$46.1M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37.3M
4
MTCH icon
Match Group
MTCH
+$28.2M
5
GXO icon
GXO Logistics
GXO
+$19.7M

Sector Composition

Rank Sector Weight
1 Technology 23.91%
2 Financials 14.2%
3 Healthcare 13.07%
4 Consumer Discretionary 12.09%
5 Communication Services 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MU icon
101
Micron Technology
MU
$937B
$132M 0.18%
1,855,914
-55,301
-3% -$4.15M
CI icon
102
Cigna
CI
$74.5B
$129M 0.17%
644,163
+10,115
+2% +$2.2M
EQIX icon
103
Equinix
EQIX
$102B
$126M 0.17%
159,803
-3,784
-2% -$3.14M
TFC icon
104
Truist Financial
TFC
$63.4B
$126M 0.17%
2,147,339
-81,525
-4% -$4.56M
TMUS icon
105
T-Mobile US
TMUS
$190B
$125M 0.17%
981,995
-38,541
-4% -$5.37M
COF icon
106
Capital One
COF
$134B
$124M 0.17%
764,825
-23,820
-3% -$3.89M
GM icon
107
General Motors
GM
$76.9B
$123M 0.17%
2,338,772
+65,387
+3% +$3.48M
MO icon
108
Altria Group
MO
$114B
$123M 0.17%
2,695,789
-143,767
-5% -$6.94M
EW icon
109
Edwards Lifesciences
EW
$51.1B
$122M 0.17%
1,078,798
-11,416
-1% -$1.3M
CL icon
110
Colgate-Palmolive
CL
$71.6B
$121M 0.16%
1,603,893
-3,695
-0.2% -$293K
FIS icon
111
Fidelity National Information Services
FIS
$23.1B
$119M 0.16%
981,815
-25,982
-3% -$3.48M
SHW icon
112
Sherwin-Williams
SHW
$86B
$118M 0.16%
422,019
-21,866
-5% -$6.4M
CME icon
113
CME Group
CME
$95.7B
$116M 0.16%
600,680
-33,447
-5% -$6.78M
CB icon
114
Chubb
CB
$134B
$116M 0.16%
667,499
-42,433
-6% -$7.44M
DUK icon
115
Duke Energy
DUK
$96.9B
$113M 0.15%
1,159,554
-40,770
-3% -$4.22M
CSX icon
116
CSX Corp
CSX
$92.3B
$112M 0.15%
3,751,208
-136,825
-4% -$4.38M
SO icon
117
Southern Company
SO
$107B
$111M 0.15%
1,794,370
-28,710
-2% -$1.85M
EL icon
118
Estee Lauder
EL
$30.6B
$111M 0.15%
369,580
-6,874
-2% -$2.25M
ICE icon
119
Intercontinental Exchange
ICE
$85.2B
$109M 0.15%
952,752
-23,975
-2% -$2.85M
ITW icon
120
Illinois Tool Works
ITW
$83B
$108M 0.15%
522,918
-20,835
-4% -$4.7M
FISV
121
Fiserv Inc
FISV
$29B
$108M 0.15%
991,811
-25,198
-2% -$2.82M
BSX icon
122
Boston Scientific
BSX
$70.2B
$107M 0.15%
2,470,745
-79,749
-3% -$3.53M
WM icon
123
Waste Management
WM
$90.5B
$105M 0.14%
702,017
-33,235
-5% -$4.97M
EMR icon
124
Emerson Electric
EMR
$86.7B
$104M 0.14%
1,103,875
-19,381
-2% -$1.93M
NSC icon
125
Norfolk Southern
NSC
$75.6B
$102M 0.14%
428,227
-13,816
-3% -$3.54M

Similar funds

RhumbLine Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 93 new positions and exited 46, leaving the 3,088-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
  • RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
  • RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
  • RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
  • RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
  • RhumbLine Advisers opened 93 new positions and closed 46 in Q3 2021.
  • RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.

Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.